Our Management Team
Dr. James McIlroy MBChB
Founder and Director
Dr. James Clark PhD
Chief Executive Officer
James is a seasoned biotechnology c-level executive with an extensive track record of creating value in biotechnology business ventures. He was previously VP of Clinical Laboratory Operations at Inivata, a global cancer genomics company that is developing products to support cancer diagnosis. His previous roles include Chief Technology Officer at Enterome, a Paris-based microbiome company with advanced technology and products, Vice President of Research and Development at MDxHealth SA, and Chief Operating Officer at Response Genetics (IPO:NASDAQ).
James has raised over $100m in private and public placements and has significant experience in building and managing high performance teams in the biotechnology sector. He has been first author or co-author in a number of high-profile peer reviewed academic papers in journals such as Nature Genetics.
Chief Operating Officer
Gregor is a thirteen-year veteran of the Scottish life sciences industry and its SME ecosystem. He was a former production manager and senior team member at Roslin Cells, overseeing the design, build and relocation to their state-of-the-art GMP manufacturing facility. Most recently he has been a director, board member and commercial advisor on behalf of Innova Partnerships Ltd, helping to support growth of several early stage Life Science businesses. Gregor completed a Saltire Fellowship at Babson College, an MBA-style development programme focused on equipping ambitious business executives with the skills they need to scale high growth companies.
Nic Robinson CSci, FIBMS, BSc
Nic has over 35 years experience in medical laboratories including over 20 years in Cellular Therapies and the manufacture of novel medicinal products for therapeutic use.
He previously led the set up and management of a peripheral blood stem cell unit at Aberdeen Transfusion Centre and was successfully audited by both the MHRA and HTA for processing, storage and transplant. He was Production Manager for the development of a Cytotoxic T cell bank as an ATMP within SNBTS for therapeutic use, which also achieved an MHRA ‘Specials’ licence. During this period he sat on the National Transfusion red book guidelines committee for Cellular Therapies, assisted with several MHRA inspections within SNBTS and developed a closed process for stem cell processing.
Nic is a Fellow in Biomedical Science and Chartered Scientist. He is also a guest lecturer on regulatory affairs at the University of Aberdeen.